Hospira touts non-DEHP offerings
This article was originally published in The Gray Sheet
Executive Summary
Lake Forest, Ill. firm announces plans to add 40 new infusion therapy medication delivery sets to its offerings of non-DEHP medical devices by early 2005. Hospira now markets roughly 80 products that do not use the polyvinyl chloride plasticizer, which, in 2003, was added to the California Environmental Protection Agency's Prop. 65 list of chemicals known to cause reproductive toxicity (1"The Gray Sheet" Oct. 27, 2003, In Brief). In 2002, FDA issued a 2public health notification recommending use of DEHP alternatives, followed by a 3draft guidance on PVC devices...
You may also be interested in...
DEHP blacklisted in California
Polyvinyl chloride plasticizer is added to the California Environmental Protection Agency's 1Proposition 65 list of chemicals known to cause reproductive toxicity. Developmental and male reproductive influences are cited by the Office of Environmental Health Hazard Assessment's listing of DEHP, which Sacramento-based Health Care Without Harm anticipated in an Oct. 21 release. In 2002, FDA issued a 2public health notification recommending use of DEHP alternatives, followed by a 3draft guidance on PVC devices...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.